National Healthcare Disparities Report - LDI Health Economist

More documents

Recommendations

Info

Effectiveness of Care Chronic Kidney Disease Importance Mortality Total ESRD deaths (2009) ................................................................................................87,812 (USRDS, 2009) Chapter 2 Chronic Kidney Disease Prevalence Total cases (2007)..............................................................................................................514,642 (NCHS, 2011) Incidence Number of new cases (2007)..........................................................................................110,996 (USRDS, 2009) Cost Total ESRD Medicare program expenditures (2007) ............................................$23.9 billion (USRDS, 2009) Measures The NHQR and NHDR track several measures of management of chronic kidney disease to assess the quality of care provided to renal dialysis patients. A previous core measure, adequacy of dialysis, was retired because it achieved a rate above 95%. Three measures are highlighted here: Findings n Nephrology care before kidney failure. n Use of arteriovenous fistula (AVF) at first outpatient dialysis. n Registration for transplantation. NEW Management: Nephrology Care Before Kidney Failure Early referral to a nephrologist is important for patients with progressive chronic kidney disease approaching kidney failure. Mindful management during the transition to ESRD permits informed selection of renal replacement therapy, placement and maturation of vascular access, and workup for kidney transplantation. Patients who begin nephrology care more than a year before kidney failure are less likely to begin dialysis with a catheter, experience infections related to vascular access, or die during the months after dialysis initiation (USRDS, 2010). 66 National Healthcare Disparities Report, 2011
Effectiveness of Care Figure 2.12. Patients beginning nephrology care more than 12 months before start of dialysis, by race and ethnicity, 2006-2008 50 45 White Black AI/AN API 50 45 Total Non-Hispanic White Hispanic 40 40 35 35 Percent 30 25 20 15 10 5 0 2006 2007 2008 Key: AI/AN = American Indian or Alaska Native; API = Asian or Pacific Islander. Source: National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Renal Data System, 2006-2008. Denominator: New end stage renal disease patients. Percent 30 25 20 15 10 5 0 2006 2007 2008 Chapter 2 Chronic Kidney Disease n In 2008, only 28% of new ESRD patients began nephrology care more than 12 months before start of dialysis (Figure 2.12). n In all years, Blacks and APIs were less likely than Whites and Hispanics were less likely than non- Hispanic Whites to begin nephrology care more than 12 months before start of dialysis. Also, in the NHQR: n In all years, patients ages 0-19, 45-64, 65-74, and 75 and over were more likely to receive nephrology care than patients ages 20-44. Management: Use of Arteriovenous Fistula at First Outpatient Dialysis For people with ESRD, dialysis can accommodate for lost kidney function by balancing minerals and water in the blood and removing waste. Vascular access is needed to reach blood vessels so dialysis can be performed. An AVF is the preferred type of access for most hemodialysis patients for three reasons: It provides adequate blood flow for dialysis, it lasts a long time, and it has a low complication rate compared with other methods. Although there is consensus that AVF should be the primary method of vascular access, AVF utilization has historically been very low. Therefore, the Centers for Medicare & Medicaid Services (CMS) has sought to increase rates of AVF for primary access by forming a nationwide initiative and collaborative effort to increase overall use of AVF. In 2005, the CMS Fistula First Breakthrough Initiative set the goal for national prevalence of AVF at 66%. National Healthcare Disparities Report, 2011 67
Page 1:
NATIONAL HEALTHCARE DISPARITIES REP
Page 4 and 5:
Acknowledgments The NHQR and NHDR a
Page 6 and 7:
National Healthcare Disparities Rep
Page 8 and 9:
Highlights New this year, the Highl
Page 10 and 11:
Highlights n Disparities in quality
Page 12 and 13:
Highlights n Quality is improving s
Page 14 and 15:
Highlights Figure H.6. Number and p
Page 16 and 17:
Highlights Table H.2. Quality measu
Page 18 and 19:
Highlights n Disparities also chang
Page 20 and 21:
Highlights Figure H.9. Income-relat
Page 22 and 23: Highlights Progress in Patient Safe
Page 24 and 25: Highlights available to the public
Page 26 and 27: Highlights Examples of Initiatives
Page 28 and 29: Highlights Provider: When referring
Page 30 and 31: Highlights State: The Ohio Plan To
Page 32 and 33: Highlights Figure H.15. Number and
Page 34 and 35: Highlights to have high health care
Page 36 and 37: Highlights n Data on disparities ar
Page 38 and 39: Highlights share experiences and di
Page 40 and 41: Highlights References Andrulis DP,
Page 42 and 43: Introduction and Methods With rapid
Page 44 and 45: Introduction and Methods a new sect
Page 46 and 47: Introduction and Methods Table 1.2.
Page 48 and 49: Introduction and Methods antibiotic
Page 50 and 51: Introduction and Methods Progress o
Page 52 and 53: Introduction and Methods n Trends o
Page 54 and 55: Introduction and Methods Reporting
Page 56 and 57: Effectiveness of Care Cancer Import
Page 58 and 59: Effectiveness of Care Chapter 2 Can
Page 60 and 61: Effectiveness of Care Treatment: Re
Page 62 and 63: Effectiveness of Care Also, in the
Page 64 and 65: Effectiveness of Care Importance Ca
Page 68 and 69: Effectiveness of Care Chapter 2 Car
Page 74 and 75: Effectiveness of Care Figure 2.13.
Page 76 and 77: Effectiveness of Care Diabetes Impo
Page 78 and 79: Effectiveness of Care Multivariate
Page 80 and 81: Effectiveness of Care Focus on Indi
Page 82 and 83: Effectiveness of Care HIV and AIDS
Page 84 and 85: Effectiveness of Care To normalize
Page 86 and 87: Effectiveness of Care HIV/AIDS core
Page 88 and 89: Effectiveness of Care Outcome: Deat
Page 90 and 91: Effectiveness of Care Findings NEW
Page 96 and 97: Effectiveness of Care Prevention: W
Page 98 and 99: Effectiveness of Care Mental Health
Page 104 and 105: Effectiveness of Care NEW Musculosk
Page 106 and 107: Effectiveness of Care n In all year
Page 108 and 109: Effectiveness of Care NEW Managemen
Page 110 and 111: Effectiveness of Care Findings Prev
Page 114 and 115: Effectiveness of Care Chapter 2 Res
Page 116 and 117: Effectiveness of Care Lifestyle Mod
Page 118 and 119: Effectiveness of Care n In 5 out of
Page 120 and 121: Effectiveness of Care NEW Outcome:
Page 122 and 123:
Effectiveness of Care Chapter 2 Lif
Page 124 and 125:
Effectiveness of Care Figure 2.49.
Page 126 and 127:
Effectiveness of Care Functional St
Page 128 and 129:
Effectiveness of Care Chapter 2 Fun
Page 130 and 131:
Effectiveness of Care at admission
Page 132 and 133:
Effectiveness of Care Supportive an
Page 134 and 135:
Effectiveness of Care n The 2008 to
Page 136 and 137:
Effectiveness of Care Chapter 2 Sup
Page 138 and 139:
Effectiveness of Care Figure 2.58.
Page 140 and 141:
Effectiveness of Care References 20
Page 142 and 143:
Effectiveness of Care Centers for M
Page 144 and 145:
Effectiveness of Care Oral health i
Page 146 and 147:
140 National Healthcare Disparities
Page 148 and 149:
Patient Safety To Err Is Human does
Page 150 and 151:
Patient Safety Figure 3.1. Adult su
Page 152 and 153:
Patient Safety Also, in the NHQR: n
Page 154 and 155:
Patient Safety n From 2006-2007 to
Page 156 and 157:
Patient Safety n From 2004 to 2008,
Page 158 and 159:
Patient Safety Chapter 3 n From 200
Page 160 and 161:
Page 162 and 163:
Timeliness Findings Getting Care fo
Page 164 and 165:
Timeliness Chapter 4 n Not all pati
Page 166 and 167:
Timeliness Chapter 4 n Among heart
Page 168 and 169:
Page 170 and 171:
Patient Centeredness Chapter 5 Simi
Page 172 and 173:
Patient Centeredness Figure 5.1. Ad
Page 174 and 175:
Patient Centeredness Figure 5.3. Ch
Page 176 and 177:
Patient Centeredness Figure 5.5. Ad
Page 178 and 179:
Patient Centeredness Patient Langua
Page 180 and 181:
Patient Centeredness Information ab
Page 182 and 183:
Patient Centeredness Providers Aski
Page 184 and 185:
178 National Healthcare Quality Rep
Page 186 and 187:
Care Coordination Importance Chapte
Page 188 and 189:
Care Coordination n In 2009, Americ
Page 190 and 191:
Care Coordination Figure 6.3. Paren
Page 192 and 193:
Care Coordination Also, in the NHQR
Page 194 and 195:
Care Coordination Chapter 6 n Overa
Page 196 and 197:
Care Coordination Chapter 6 n Overa
Page 198 and 199:
Efficiency Findings Chapter 7 Inapp
Page 200 and 201:
Efficiency Figure 7.2. Potentially
Page 202 and 203:
Efficiency Comparisons with the 3 S
Page 204 and 205:
Efficiency Perforated Appendixes Pe
Page 206 and 207:
Efficiency Figure 7.8. Males age 75
Page 208 and 209:
Page 210 and 211:
Health System Infrastructure Eviden
Page 212 and 213:
Health System Infrastructure Figure
Page 214 and 215:
Health System Infrastructure Figure
Page 216 and 217:
Health System Infrastructure Occupa
Page 218 and 219:
Health System Infrastructure n From
Page 220 and 221:
Health System Infrastructure NEW Co
Page 222 and 223:
Health System Infrastructure Table
Page 224 and 225:
Health System Infrastructure Refere
Page 226 and 227:
Access to Health Care Findings Heal
Page 228 and 229:
Access to Health Care Figure 9.2. P
Page 230 and 231:
Page 232 and 233:
Access to Health Care Financial Bur
Page 234 and 235:
Access to Health Care Chapter 9 n O
Page 236 and 237:
Page 238 and 239:
Priority Populations Chapter 10 232
Page 240 and 241:
Priority Populations AHRQ’s Prior
Page 242 and 243:
Priority Populations Blacks or Afri
Page 244 and 245:
Priority Populations Hispanics or L
Page 246 and 247:
Priority Populations Geographic are
Page 248 and 249:
Priority Populations criminal justi
Page 250 and 251:
Priority Populations Postponement R
Page 252 and 253:
Priority Populations References Adl
Page 254 and 255:
Page 256:
U.S. Department of Health and Human
show all

National Healthcare Disparities Report - LDI Health Economist

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?